Literature DB >> 20027338

Clinical significance of hyperexpression of epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell carcinoma.

V V Delektorskaya1, G Yu Chemeris, P V Kononets, A Yu Grigorchuk.   

Abstract

Immunohistochemical study of marker expression in primary tumors of patients with esophageal squamous-cell carcinoma was carried out in order to evaluate prognostic significance of EGFR and HER-2 levels in the tumors. Hyperexpression of EGFR and HER-2 in the tumors is an important marker for the analysis of prognosis and clinical course of the disease. A relationship between high levels of EGFR and HER-2 in the tumors of patients with esophageal squamous-cell carcinoma and intravascular tumor invasion (p=0.038) and poor outcome of the disease (p=0.019) was detected. The results indicate that evaluation of changes in the expression of EGFR and HER-2 in tumors is essential for individual prediction of the disease course and development of new approaches to the treatment of these tumors, including target therapy aimed at these tyrosine kinase receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20027338     DOI: 10.1007/s10517-009-0659-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.

Authors:  Zhenbing You; Dafu Xu; Jian Ji; Wei Guo; Weiguo Zhu; Jingdong He
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

2.  The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Adenocarcinoma Referred to a Lung Diseases Hospital; A Cross-Sectional Study from Iran.

Authors:  Sotoudeh Mohammadi; Mitra Rezaei; Fatemeh Shojaeian; Mihan Pourabdollah; Leila Mohammadi Ziazi; Sharareh Seifi; Atousa Doroudinia; Babak Salimi; Adnan Khosravi; Mohammad Amin Farhangnasab
Journal:  Iran J Pathol       Date:  2022-02-20

3.  miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.

Authors:  Mingxin Zhang; Qi Yang; Lingmin Zhang; Suna Zhou; Wenguang Ye; Qinglin Yao; Zongfang Li; Cheng Huang; Qinsheng Wen; Jingjie Wang
Journal:  J Exp Clin Cancer Res       Date:  2014-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.